Privium Fund Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Privium Fund Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-251,158	Closed	-$5.35M	–	137
2024 Q1	$5.35M	Buy	251,158 +109,408	+77%	+$1.31M	1.43%	22
2023 Q4	$1.17M	Buy	+141,750	New	+$689K	0.33%	37

Privium Fund Management's FUSN Position: Q2 2024 in Review

Privium Fund Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 251,158 shares — an estimated $5.35M sold.

Privium Fund Management first reported a position in FUSN in Q4 2023 and held it in 2 quarters. The position peaked at $5.35M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

Privium Fund Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
Privium Fund Management sold 251,158 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $5.35M.
Privium Fund Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q4 2023 and held it in 2 quarters.
Privium Fund Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $5.35M in Q1 2024.
0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Privium Fund Management's 13F filing for Q2 2024, filed 1 Aug 2024.